Showing 2,121 - 2,140 results of 2,232 for search '"Texas A', query time: 0.10s Refine Results
  1. 2121
  2. 2122
  3. 2123
  4. 2124
  5. 2125
  6. 2126
  7. 2127

    Analyzing frequency spectrum and Total Harmonic Distortion for high switching frequency operation of GaN-based filter-less multilevel cascaded H-bridge inverter by Ramkrishna Mishan, Xingang Fu, Chanakya Hingu, Poria Fajri

    Published 2025-03-01
    “…Experimental outcomes indicate a notable frequency spectrum change with high-level and high switching frequency operation, corroborating the efficacy of filterless GaN switches. …”
    Get full text
    Article
  8. 2128
  9. 2129

    Constructing Identities: Amos Tutuola and the Ibadan Literary Elite in the wake of Nigerian Independence by Mackenzie Finley

    Published 2021-12-01
    “…Yet if education represented a rather concrete, institutionalized divide between the elite and the everyday Nigerian, this paper will suggest that the resulting epistemological difference served as a more fluid, ideological divide. …”
    Get full text
    Article
  10. 2130
  11. 2131
  12. 2132
  13. 2133
  14. 2134
  15. 2135
  16. 2136
  17. 2137
  18. 2138
  19. 2139

    One-Year Outcomes in Subjects Developing Macular Neovascularization While Undergoing Avacincaptad Pegol Therapy for Geographic Atrophy by Rush RB, Klein W, Rush SW, Reinauer R

    Published 2025-01-01
    “…Ryan B Rush,1– 3 Westin Klein,1 Sloan W Rush,1,2 Robert Reinauer4 1Department of Ophthalmology, Panhandle Eye Group, Amarillo, TX, USA; 2Department of Surgery, Texas Tech University Health Science Center, Amarillo, TX, USA; 3Department of Ophthalmology, Southwest Retina Specialists, Amarillo, TX, USA; 4Department of Ophthalmology, New Vision Eye Center, Vero Beach, FL, USACorrespondence: Ryan B Rush, Southwest Retina Specialists, 7411 Wallace Blvd, Amarillo, TX, 79106, USA, Tel +1806 351 1870, Email ryan.rush.md@gmail.comPurpose: To assess the 12-month outcomes in subjects developing macular neovascularization (MNV) during intravitreal avacincaptad pegol (IVA) treatment for geographic atrophy (GA) secondary to age-related macular degeneration (AMD).Methods: This research was conducted as a case-controlled, retrospective study of AMD subjects undergoing IVA treatment for GA from two private practice institutions. …”
    Get full text
    Article
  20. 2140